3 COVID Stocks That Will Make Billions in 2022

3 COVID Stocks That Will Make Billions in 2022·Motley Fool
In this article:

Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Pfizer (NYSE: PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill.

Advertisement